These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34937050)

  • 1. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta.
    Ulrich L; Halwe NJ; Taddeo A; Ebert N; Schön J; Devisme C; Trüeb BS; Hoffmann B; Wider M; Fan X; Bekliz M; Essaidi-Laziosi M; Schmidt ML; Niemeyer D; Corman VM; Kraft A; Godel A; Laloli L; Kelly JN; Calderon BM; Breithaupt A; Wylezich C; Berenguer Veiga I; Gultom M; Osman S; Zhou B; Adea K; Meyer B; Eberhardt CS; Thomann L; Gsell M; Labroussaa F; Jores J; Summerfield A; Drosten C; Eckerle IA; Wentworth DE; Dijkman R; Hoffmann D; Thiel V; Beer M; Benarafa C
    Nature; 2022 Feb; 602(7896):307-313. PubMed ID: 34937050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 spike D614G change enhances replication and transmission.
    Zhou B; Thao TTN; Hoffmann D; Taddeo A; Ebert N; Labroussaa F; Pohlmann A; King J; Steiner S; Kelly JN; Portmann J; Halwe NJ; Ulrich L; Trüeb BS; Fan X; Hoffmann B; Wang L; Thomann L; Lin X; Stalder H; Pozzi B; de Brot S; Jiang N; Cui D; Hossain J; Wilson MM; Keller MW; Stark TJ; Barnes JR; Dijkman R; Jores J; Benarafa C; Wentworth DE; Thiel V; Beer M
    Nature; 2021 Apr; 592(7852):122-127. PubMed ID: 33636719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
    Carroll T; Fox D; van Doremalen N; Ball E; Morris MK; Sotomayor-Gonzalez A; Servellita V; Rustagi A; Yinda CK; Fritts L; Port JR; Ma ZM; Holbrook MG; Schulz J; Blish CA; Hanson C; Chiu CY; Munster V; Stanley S; Miller CJ
    PLoS Pathog; 2022 Feb; 18(2):e1009914. PubMed ID: 35143587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.
    Hou YJ; Chiba S; Halfmann P; Ehre C; Kuroda M; Dinnon KH; Leist SR; Schäfer A; Nakajima N; Takahashi K; Lee RE; Mascenik TM; Graham R; Edwards CE; Tse LV; Okuda K; Markmann AJ; Bartelt L; de Silva A; Margolis DM; Boucher RC; Randell SH; Suzuki T; Gralinski LE; Kawaoka Y; Baric RS
    Science; 2020 Dec; 370(6523):1464-1468. PubMed ID: 33184236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spike mutation D614G alters SARS-CoV-2 fitness.
    Plante JA; Liu Y; Liu J; Xia H; Johnson BA; Lokugamage KG; Zhang X; Muruato AE; Zou J; Fontes-Garfias CR; Mirchandani D; Scharton D; Bilello JP; Ku Z; An Z; Kalveram B; Freiberg AN; Menachery VD; Xie X; Plante KS; Weaver SC; Shi PY
    Nature; 2021 Apr; 592(7852):116-121. PubMed ID: 33106671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.
    Liu Y; Liu J; Plante KS; Plante JA; Xie X; Zhang X; Ku Z; An Z; Scharton D; Schindewolf C; Widen SG; Menachery VD; Shi PY; Weaver SC
    Nature; 2022 Feb; 602(7896):294-299. PubMed ID: 34818667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
    Imai M; Halfmann PJ; Yamayoshi S; Iwatsuki-Horimoto K; Chiba S; Watanabe T; Nakajima N; Ito M; Kuroda M; Kiso M; Maemura T; Takahashi K; Loeber S; Hatta M; Koga M; Nagai H; Yamamoto S; Saito M; Adachi E; Akasaka O; Nakamura M; Nakachi I; Ogura T; Baba R; Fujita K; Ochi J; Mitamura K; Kato H; Nakajima H; Yagi K; Hattori SI; Maeda K; Suzuki T; Miyazato Y; Valdez R; Gherasim C; Furusawa Y; Okuda M; Ujie M; Lopes TJS; Yasuhara A; Ueki H; Sakai-Tagawa Y; Eisfeld AJ; Baczenas JJ; Baker DA; O'Connor SL; O'Connor DH; Fukushi S; Fujimoto T; Kuroda Y; Gordon A; Maeda K; Ohmagari N; Sugaya N; Yotsuyanagi H; Mitsuya H; Suzuki T; Kawaoka Y
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34140350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
    Salleh MZ; Derrick JP; Deris ZZ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
    Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
    EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
    Volz E; Hill V; McCrone JT; Price A; Jorgensen D; O'Toole Á; Southgate J; Johnson R; Jackson B; Nascimento FF; Rey SM; Nicholls SM; Colquhoun RM; da Silva Filipe A; Shepherd J; Pascall DJ; Shah R; Jesudason N; Li K; Jarrett R; Pacchiarini N; Bull M; Geidelberg L; Siveroni I; ; Goodfellow I; Loman NJ; Pybus OG; Robertson DL; Thomson EC; Rambaut A; Connor TR
    Cell; 2021 Jan; 184(1):64-75.e11. PubMed ID: 33275900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making sense of spike D614G in SARS-CoV-2 transmission.
    Shi AC; Xie X
    Sci China Life Sci; 2021 Jul; 64(7):1062-1067. PubMed ID: 33587268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants.
    Vesper N; Ortiz Y; Bartels-Burgahn F; Yang J; de la Rosa K; Tenbusch M; Schulz S; Finzel S; Jäck HM; Eibel H; Voll RE; Reth M
    Front Immunol; 2021; 12():730766. PubMed ID: 34630410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
    Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
    Elife; 2021 Feb; 10():. PubMed ID: 33570490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.
    Ozono S; Zhang Y; Ode H; Sano K; Tan TS; Imai K; Miyoshi K; Kishigami S; Ueno T; Iwatani Y; Suzuki T; Tokunaga K
    Nat Commun; 2021 Feb; 12(1):848. PubMed ID: 33558493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route.
    Pan T; Chen R; He X; Yuan Y; Deng X; Li R; Yan H; Yan S; Liu J; Zhang Y; Zhang X; Yu F; Zhou M; Ke C; Ma X; Zhang H
    Signal Transduct Target Ther; 2021 Dec; 6(1):420. PubMed ID: 34907154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility.
    Zhou B; Thao TTN; Hoffmann D; Taddeo A; Ebert N; Labroussaa F; Pohlmann A; King J; Portmann J; Halwe NJ; Ulrich L; Trüeb BS; Kelly JN; Fan X; Hoffmann B; Steiner S; Wang L; Thomann L; Lin X; Stalder H; Pozzi B; de Brot S; Jiang N; Cui D; Hossain J; Wilson M; Keller M; Stark TJ; Barnes JR; Dijkman R; Jores J; Benarafa C; Wentworth DE; Thiel V; Beer M
    bioRxiv; 2020 Oct; ():. PubMed ID: 33140052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.